About
Falsification is the method. The surviving edge is the product.
The Refutation is a quant markets research letter with an unusual editorial policy: we publish the strategies that failed as prominently as the ones that worked. It is not a "nothing works" project. It's a survivorship filter. Roughly twenty strategy ideas go into the guillotine; most get a headstone; a handful survive honest out-of-sample testing and get real capital behind them. The refutations are what earn your trust. The rare survivors are the product.
The whole identity is methodological honesty. We show process — base rates, next-bar fills, netted fees, out-of-sample regime testing, and what killed an edge — rather than forecasts. We sell credibility and method, never signals or personalised advice. That's both our compliance posture and our selling proposition: if you can't trust the person testing the strategy, the backtest is worthless.
Who writes it
The Refutation is written by Daniel Roache, an independent systematic trader and quant researcher based in Australia. Daniel designs trading strategies, puts them through a two-tier out-of-sample harness, and runs the survivors as live automated systems on real capital. The letter is a direct by-product of that day-to-day work: the same tests, the same graveyard, written up in plain English.
He isn't an anonymous account posting screenshots. Every note carries a named author who stands behind the method, because in this field that accountability is the product. When a strategy is refuted, you see exactly how and why. When one survives, you see the bar it had to clear.
- Honest verdicts — refuted far more often than survived.
- Method and evidence, never buy/sell signals or price targets.
- Clear disclosure of AI-assisted drafting, always human-reviewed before publishing.
- No hype vocabulary — no "guaranteed," "risk-free," or "get in before."
What it isn't
This is not a signals service, a Discord "pump" room, a course promising financial freedom, or personal advice. Nothing published here accounts for your objectives, situation or needs, and none of it is a recommendation to buy, sell or hold any financial product. If you want a recommendation, see a licensed adviser. What we offer is the ability to think about markets like a sceptic — and the receipts to back it up.
Start with the method
- Why most backtested edges are statistical mirages
- Out-of-sample testing: the harness that kills most edges
- Survivorship bias in backtesting, explained
- 10 signs your trading strategy is overfit
Follow the work
Free refutations in your inbox; paid members get the survivor research and full backtests.
No signals. No spam. Education and data-journalism only.